OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K‐Akt signaling in gastric cancer
Cheng Zhang, Mengqi Zhang, Sai Ge, et al.
Cancer Medicine (2019) Vol. 8, Iss. 10, pp. 4766-4781
Open Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang, Hengyou Weng, Jianjun Chen
Cancer Cell (2020) Vol. 37, Iss. 3, pp. 270-288
Open Access | Times Cited: 923

The potential role of RNA N6-methyladenosine in Cancer progression
Tianyi Wang, Shan Kong, Mei Tao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 788

The role of m6A RNA methylation in cancer metabolism
Yuanyuan An, Hua Duan
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 467

Mechanism of RNA modification N6-methyladenosine in human cancer
Zijian Zhou, Jiancheng Lv, Hao Yu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 224

Insights into N6-methyladenosine and programmed cell death in cancer
Li Liu, Hui Li, Dingyu Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 172

LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression
Tong Sun, Zhikun Wu, Xiufang Wang, et al.
Oncogene (2020) Vol. 39, Iss. 31, pp. 5358-5372
Closed Access | Times Cited: 166

Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100720-100720
Closed Access | Times Cited: 140

The mechanism of m6A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene
Shuiping Liu, Qiujie Li, Guohua Li, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 140

m6A regulator‐mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis
Xiaoqi Zhang, Shizhen Zhang, Xinyu Yan, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 7, pp. 3634-3645
Open Access | Times Cited: 103

The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis
Mohammad B. Uddin, Zhishan Wang, Chengfeng Yang
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 103

Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
Qian Guan, Huiran Lin, Lei Miao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 80

m6A modification suppresses ocular melanoma through modulating HINT2 mRNA translation
Ruobing Jia, Peiwei Chai, Shanzheng Wang, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 142

RNA methylations in human cancers
Xiao Han, Mengke Wang, Yongliang Zhao, et al.
Seminars in Cancer Biology (2020) Vol. 75, pp. 97-115
Closed Access | Times Cited: 133

FTO – A Common Genetic Basis for Obesity and Cancer
Ning Lan, Ying Lu, Yigan Zhang, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 128

The role of N6-methyladenosine mRNA in the tumor microenvironment
Min Li, Xuan Zha, Shengjun Wang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1875, Iss. 2, pp. 188522-188522
Closed Access | Times Cited: 101

METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
Dong-Dong Yang, Zhan‐Hong Chen, Kai Yu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 99

High expression of WTAP leads to poor prognosis of gastric cancer by influencing tumour‐associated T lymphocyte infiltration
Huafu Li, Qiao Su, Bo Li, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 8, pp. 4452-4465
Open Access | Times Cited: 99

KIAA1429 regulates cell proliferation by targeting c‐Jun messenger RNA directly in gastric cancer
Ran Miao, Congcong Dai, Lin Mei, et al.
Journal of Cellular Physiology (2020) Vol. 235, Iss. 10, pp. 7420-7432
Closed Access | Times Cited: 97

RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications
Chang Gu, Xin Shi, Chenyang Dai, et al.
The Innovation (2020) Vol. 1, Iss. 3, pp. 100066-100066
Open Access | Times Cited: 96

The evolving landscape of N6-methyladenosine modification in the tumor microenvironment
Yunru Gu, Xi Wu, Jingxin Zhang, et al.
Molecular Therapy (2021) Vol. 29, Iss. 5, pp. 1703-1715
Open Access | Times Cited: 87

Multiple Functions and Mechanisms Underlying the Role of METTL3 in Human Cancers
Wenhui Zheng, Xiaoshen Dong, Yan Zhao, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 83

N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications
Binbin Hu, X. Wang, Xuyu Gu, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 81

N6-methyladenosine ALKBH5 promotes non-small cell lung cancer progress by regulating TIMP3 stability
Zhiyuan Zhu, Qi Qian, Xia Zhao, et al.
Gene (2020) Vol. 731, pp. 144348-144348
Closed Access | Times Cited: 81

Page 1 - Next Page

Scroll to top